MENU
+Compare
INCY
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$59.73
Change
+$0.18 (+0.30%)
Capitalization
11.56B

INCY Incyte Corp Forecast, Technical & Fundamental Analysis

Incyte focuses on the discovery and development of small-molecule drugs... Show more

Industry: #Biotechnology
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for INCY with price predictions
May 07, 2025

INCY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for INCY turned positive on April 15, 2025. Looking at past instances where INCY's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INCY's RSI Indicator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on INCY as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INCY advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where INCY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for INCY moved below the 200-day moving average on April 09, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INCY broke above its upper Bollinger Band on April 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for INCY entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.147) is normal, around the industry mean (14.238). P/E Ratio (298.050) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.107) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.746) is also within normal values, averaging (252.967).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INCY is expected to report earnings to rise 17.24% to $1.36 per share on August 05

Incyte Corp INCY Stock Earnings Reports
Q2'25
Est.
$1.36
Q1'25
Beat
by $0.12
Q4'24
Missed
by $0.08
Q3'24
Beat
by $0.04
Q2'24
Missed
by $2.69
The last earnings report on April 29 showed earnings per share of $1.16, beating the estimate of $1.04. With 2.17M shares outstanding, the current market capitalization sits at 11.56B.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1801 Augustine Cut-Off
Phone
+1 302 498-6700
Employees
2524
Web
https://www.incyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PKW113.940.99
+0.88%
Invesco BuyBack Achievers ETF
VV260.441.97
+0.76%
Vanguard Large-Cap ETF
GGME52.550.21
+0.40%
Invesco Next Gen Media and Gaming ETF
NUSA23.20-0.05
-0.24%
Nuveen ESG 1-5 Year US Aggt Bd ETF
GMF116.71-0.59
-0.50%
SPDR® S&P Emerging Asia Pacific ETF

INCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with REGN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
+0.30%
REGN - INCY
39%
Loosely correlated
-2.36%
AXON - INCY
39%
Loosely correlated
+14.13%
TECH - INCY
37%
Loosely correlated
+2.11%
XENE - INCY
35%
Loosely correlated
+0.59%
KYMR - INCY
34%
Loosely correlated
+5.70%
More